Table 1.
Demographic data of cancer patients with confirmed gastrointestinal bleeding
| Demographic data | N = 147 | |||
|---|---|---|---|---|
| Gender | ||||
| Male | 90 | 61.2% | ||
| Female | 57 | 38.8% | ||
| Cancer | ||||
| GI | 85 | 57.8% | ||
| Breast | 12 | 8.2% | ||
| Lung | 8 | 5.4% | ||
| Lymphoma | 9 | 6.1% | ||
| Head and neck | 6 | 4.1% | ||
| Leukemia | 5 | 3.4% | ||
| Prostate | 5 | 3.4% | ||
| Ovary | 4 | 2.7% | ||
| Kidney | 3 | 2.1% | ||
| Others | 10 | 6.8% | ||
| Clinical presentation | ||||
| Hematemesis | 67 | 45.6% | ||
| Melena | 40 | 27.2% | ||
| Enterorrhagia | 6 | 4.1% | ||
| Coffee-ground emesis | 5 | 3.4% | ||
| Falling hemoglobin | 23 | 15.6% | ||
| Unknown | 6 | 4.1% | ||
| Endoscopic treatment | ||||
| Elastic banding | 20 | 31.7% | ||
| Combined therapy (injection + clip or coagulation) | 10 | 15.9% | ||
| APC | 10 | 15.9% | ||
| Hemoclips | 7 | 11.1% | ||
| Adrenaline injection | 7 | 11.1% | ||
| Cyanoacrylate injection | 5 | 7.9% | ||
| Variceal sclerotherapy | 2 | 3.2% | ||
| Cyanoacrylate injection + elastic banding | 2 | 3.2% |